CD34 and acute myeloid leukemia: Nested RT-PCR analysis (required due to low cell numbers, particularly in the post-treatment samples) revealed that 6 out of 8 patients analyzed exhibited NY-ESO-1 expression in CD34+ blasts following decitabine treatment (Figure 4), indicating induction of NY-ESO-1 occurred in the AML blasts.